Sharon Bio Medicine on Thursday informed the exchanges that its API plant at Raigad has received approval to operate from the pollution control board. On March 6, the company had said the unit was suspending operations ‘temporarily’ following the directions of the Central Pollution Control Board. However, financial implications of the suspension are not known immediately. Shareholders of Sharon Bio Medicine would monitor the development closely.